×

Health Care Equipment and Supplies Health Care Equipment

  • Oct 20- The head of the U.S. Food and Drug Administration said the agency was working with several pharmaceutical and medical device companies in Puerto Rico to prevent shortages of medical products in the United States as it joins a massive effort to help rebuild the island that was ravaged by Hurricane Maria. FDA Commissioner Scott Gottlieb said the agency...

  • Jude Medical and Alere, to bolster its medical devices business, and favorable tax laws in India are boosting its generics business. The company's shares rose 2.8 percent to $56.60 to a record in morning trading. Sales in the medical devices business rose 6.5 percent to $2.60 billion, accounting for more than a third of total sales.

  • Abbott forecast full-year adjusted 2017 profit from continuing operations of $2.48- $2.50 per share. It had earlier expected earnings per share of $2.43- $2.53. Several devices received U.S. Food and Drug Administration approvals in the quarter, including Abbott's FreeStyle Libre glucose monitoring system and two of its heart devices- HeartMate 3 and...

  • Jude Medical acquisition, with sales rising 6.5 percent to $2.60 billion in the third quarter ended Sept. 30. Net sales rose to $6.83 billion from $5.30 billion. Net earnings rose to $603 million, or 34 cents per share, in the quarter, from a loss of $329 million, or 22 cents per share, a year earlier.

  • OrthoPediatrics celebrates initial public offering by ringing Friday's opening bell at the Nasdaq MarketSite.

  • The Johnson & Johnson logo

    Johnson & Johnson notched its second upgrade this week after Jefferies raised its rating to buy from hold.

  • *Sees EBITA hit of 20 mln euros in Q4, 60 mln euros in 2018. AMSTERDAM, Oct 11- Health technology company Philips is suspending the manufacture of some defibrillators in the United States and will make others under heightened scrutiny following criticisms from U.S. regulators, in a move it said would dent profits. Philips disclosed details of the current dispute in...

  • Flirtey drones will deliver defibrillators to victims of cardiac arrest in Nevada.

    A start-up named Flirtey has teamed up with a Nevada emergency services company to deliver defibrillators to people suffering cardiac arrest.

  • Oct 9- Wall Street declined on Monday as gains in Microsoft and other technology stocks failed to offset a dip in Medtronic and other healthcare stocks. The S&P healthcare index moved down 0.76 percent, weighed by a 3.6- percent slide in Medtronic after the medical device maker warned that its quarterly profit would be impacted after Hurricane Maria hit its...

  • Johnson & Johnson Listerine brand cool mint mouthwash bottles move through the production line on a conveyor at the J&J consumer healthcare products plant in Lititz, Pennsylvania.

    Wells Fargo raises its rating on Johnson & Johnson, saying that improved performance could lead to better third-quarter results.

  • Oct 5- Johnson& Johnson's diabetes care unit, which makes insulin pumps, said on Thursday it would shut its business in United States and Canada amid increased competition and after failing to find a buyer. Animas Corp has selected rival Medtronic Plc as its partner for the device and nearly 90,000 patients using its pumps will be offered the option to transfer to...

  • Oct 5- Animas Corp, Johnson& Johnson's diabetes care unit, said it intends to exit the insulin pump business due to increased competition and has selected rival Medtronic Plc as its partner for the device. Animas said it has discontinued the sale of all Animas Vibe and OneTouch Ping insulin pumps in the United States and Canada, effective immediately.

  • The coronal view of a human brain of a patient suffering from Parkinson's disease

    This pacemaker for the brain can be used to treat symptoms of neurological disorders, like Parkinson’s disease.

  • Oct 5- Animas Corp, Johnson& Johnson's diabetes care unit, said it intends to exit the insulin pump business and has selected Medtronic Plc as its partner for patients on insulin pumps. Patients using an Animas insulin pump will be offered the option to transfer to a Medtronic pump, the company said on Thursday. Nearly 90,000 patients use company's pumps and...

  • Apple's 'connected health' moves will help the industry, says medical device CEO

    Jim Cramer spoke with BioTelemetry CEO Joe Capper, who said his medical device company will benefit from tech giants chasing connected health business.

  • Sept 28- Wall Street edged higher on Thursday, as the S&P 500 eked out a record on gains in McDonald's and healthcare names, while investors continued to hope President Donald Trump will be able to make progress on tax reform. Shares in the world's biggest fast food chain rose 2.23 percent, their biggest single-day percentage gain in more than two months, after...

  • Sept 28- Wall Street edged higher on Thursday, with the S&P 500 poised to close at a record on gains in McDonald's and healthcare names, while investors continued to hope President Donald Trump will be able to make progress on tax reform. Shares in the world's biggest fast food chain rose 2.36 percent, their biggest single-day percentage gain in more than two...

  • However, the Commerce Department report also showed that the economy grew a bit faster than previously estimated in the second quarter, recording its quickest pace in more than two years. The Labor Department said initial claims for state unemployment benefits increased 12,000 to a seasonally adjusted 272,000 for the week ended Sept. 23.

  • Sept 27- The U.S. Food and Drug Administration said it approved Abbott Laboratories' glucose monitoring device for adults with diabetes, allowing millions of people to track their blood sugar levels without having to prick their fingers. Chicago- based Abbott's shares were trading up 3.6 percent at $54 after the bell on Wednesday. Nowadays, advanced continuous...

  • Sept 27- The U.S. Food and Drug Administration on Wednesday approved Abbott Laboratories' glucose monitoring device for adults with diabetes, allowing millions of people to track their blood sugar levels without having to prick their fingers. Chicago- based Abbott's shares were trading up about 2 percent at $53.25 after the bell on Wednesday.